Rossi, Ernesto
Bersanelli, Melissa
Gelibter, Alain Jonathan
Borsellino, Nicolò
Caserta, Claudia
Doni, Laura
Maruzzo, Marco
Mosca, Alessandra
Pisano, Carmela
Verzoni, Elena
Zucali, Paolo Andrea
Article History
Accepted: 6 July 2021
First Online: 8 November 2021
Declarations
:
: E.R.: consultant for MSD. M.B. received research funding by Roche, Novartis, Pfizer, and Seqirus, fees for advisory role and speakers’ bureau by AstraZeneca, IPSEN, Novartis, Pierre Fabre, Pfizer, and BMS, and honoraria for copyright transfer by Sciclone Pharmaceuticals. E.V. received speakers’ bureau/advisory board fees from Pfizer, MSD, Novartis, Ipsen, and BMS. P.A.Z. reports outside the submitted work personal fees for advisory role, speaker engagements, and travel and accommodation expenses from Merck Sharp & Dohme, Astellas, Janssen, Sanofi, Ipsen, Pfizer, Novartis, Bristol Meyer Squibb, Amgen, AstraZeneca, Roche, and Bayer. The other authors declare no conflict of interest.